Nektar Therapeutics Corporation
Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.
Founded Date:
1990
Total Funding:
1200000000
Employee Number:
501-1000
Funding Status:
IPO
Number Of Exists:
1
Technology:
Biotechnology, Chemical, Health Care, Therapeutics
Last Funding Type:
Post-IPO Equity
Acquisitions Number:
2.0
Industry:
Pharma
Headquarters:
San Carlos, California, United States
Estimated Revenue:
$50M to $100M